- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
ns
FOR IMMEDIATE RELEASE
October 31, 2002
CONTACT:
Jeff Ezell
202-434-7243
Randy Burkholder
202-434-7269
FINAL OUTPATIENT RULE ADDRESSES SOME PAYMENT PROBLEMS, BUT REMAINING FLAWS POINT TO NEED FOR A SYSTEMIC FIX, ADVAMED SAYS
WASHINGTON, DC - AdvaMed said it was pleased that the Centers for Medicare & Medicaid Services (CMS) had taken steps to correct some of the more serious under-payments in the final outpatient rule released today, but called on the agency to adopt more fundamental, comprehensive solutions for the future.
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
42 CFR Part 410 and 414
[CMS-1204-FN]
RIN 0938-AL21
Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2003, Notice of Delay of Final Rule
AGENCY : Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice of Delay of Final Rule.
SUMMARY: This document gives notice of a delay in publication of the physician fee schedule for calendar year 2003
FOR FURTHER INFORMATION CONTACT:
/index.php?option=com_iwpfile&file=/dir_01/he2002_2762.pdf
FOR IMMEDIATE RELEASE
P02-45
November 1, 2002
Media Inquiries: 301-827-6242
Consumer Inquiries: 888-INFO-FDA
FDA APPROVES GENERIC OMEPRAZOLE
FIRST MARKETING OF COST-SAVING DRUG PRODUCT TO BEGIN
Accutane (isotretinoin)
Audience: Dermatologists and other healthcare professionals
FDA and Roche revised the WARNINGS: Psychiatric Disorders, Boxed CONTRAINDICATIONS AND WARNINGS, DOSAGE AND
ADMINISTRATION, and PRECAUTIONS: Drug Interactions sections of the prescribing information. Changes in pediatric labeling were made to the
CLINICAL PHARMACOLOGY: Special Patient Populations: Pediatric Patients, WARNINGS: Skeletal: Bone Mineral Density, and
/index.php?option=com_iwpfile&file=/dir_01/he2002_2759.pdf
[Federal Register: November 1, 2002 (Volume 67, Number 212)]
[Proposed Rules]
[Page 66593-66594]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01no02-32]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 314
[Docket No. 85N-0214]
180-Day Generic Drug Exclusivity for Abbreviated New Drug
Applications